Tomasz Dyląg works at European Commission’s Directorate General for Research and Innovation where he is Head of Sector for Health Industry. His responsibilities cover industrial research and innovation in the health area, regulatory science and the daily follow-up of the Innovative Health Initiative (IHI), EU’s flagship public-private partnership that brings together academia and the industry sectors of pharmaceuticals, medical devices, diagnostics, biotech and digital technologies. Prior to his current role, he was in charge of policy development and project management in various areas of health research and innovation including personalised medicine and new technologies. Tomasz Dyląg holds PhD in chemistry from the Jagiellonian University in Kraków, Poland, with special interest in pharmacology and neuroscience.